4 news items
XORTX to Present at BIO International Convention 2024
XRTX
4 Jun 24
stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce its
XORTX Reprices Balance of Warrants Issued in Connection with October 2021 US IPO
XRTX
17 May 24
, TSXV:XRTX, Frankfurt: ANU))), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease
XORTX Welcomes New Member to the Board of Directors
GMDAQ
XRTX
8 Apr 24
))), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, welcomes Abigail
XORTX Announces Participation in Spring 2024 Investor Conferences
XRTX
8 Apr 24
: A3UNZ))), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive
- Prev
- 1
- Next